Stage IV childhood kidney tumor with lung spread treatment comparison
Treatments studied
Part of Cancer clinical trials.
This study tests two different chemotherapy combinations for children whose kidney tumor has spread to the lungs (or looks highly suspicious for spread). You may be assigned to either the standard plan or an experimental plan, and the goal is to see which works better and is safest.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You (or your child) have a stage IV kidney tumor diagnosed for the first time
- The cancer has already spread to the lungs (or there is another very suspicious spot) at diagnosis
- Imaging shows at least one lung nodule or suspicious lesion that is 3 mm or larger
- A CT scan of the chest and a CT scan or MRI of the abdomen must be done to measure the spots
- The spread must be confirmed by a central (independent) review team
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether removing the kidney tumor with “deferred cytoreductive nephrectomy” (surgery at a later time) works best for people whose metastatic kidney cancer is already present. It compares a standard treatment approach using either immunotherapy (nivolumab/ipilimumab) or a targeted pill plus immunotherapy (TKI/IO), with planned surgery afterward.
This trial tests a combination of anthracycline drugs, including doxorubicin, for children with nephroblastoma (a type of kidney cancer). The goal is to see if this treatment is safe and effective for children who need this chemotherapy.
This Phase 2 trial tests combination chemotherapy for children with certain types of Wilms tumor—either newly diagnosed diffuse anaplastic Wilms tumor or favorable Wilms tumor that has come back. The goal is to see how well the treatment controls the tumor and is tolerable for children.
This trial compares standard systemic therapy (medication) alone versus systemic therapy plus targeted radiation to the cancer spots for people with kidney cancer that has spread to a limited number of places (up to 5 spots). It aims to see if adding radiation helps control the cancer better.
This study tailors treatment for children with Wilms tumor based on specific tumor features and risk factors. The goal is to give the right amount of therapy to each patient to minimize side effects while maintaining high cure rates.
This trial tests a combination of four drugs (liposomal irinotecan, vincristine, temozolomide, and anlotinib) for children and teens whose solid tumors have come back or haven't responded to standard treatment. The goal is to see if this drug mix can shrink or control the tumors.
Hear when a new Childhood Renal Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.